HAC (Russian)
RSCI (Russian)
Ulrichsweb (Ulrich’s Periodicals Directory)
Scientific Indexing Services


Download full text PDF

Professor L. Dvoretsky, MD; O. Ivleva I.M. Sechenov First Moscow State Medical University, Moscow

The paper considers the tactics of pathogenetic therapy with iron preparations in patients with iron deficiency anemia (IDA), among other issues, the route of administration, the choice of the optimal iron drug in term of a particular situation, as well as the need for maintenance therapy and side effects during treatment. It discusses the management of patients with IDA refractory to iron treatment, the causes and mechanisms of treatment refractoriness, and methods of correction.

iron deficiency anemia
iron preparations

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

  1. WHO: The World Health Report 2002 – Reducing Risks, Promoting Healthy Life.
  2. World wide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993–2005, 2009.
  3. Usacheva E.I. Kachestvo zhizni bol'nyh zhelezodefitsitnymi anemijami v otsenke effektivnosti terapii razlichnymi preparatami zheleza. Avtoref. dis. … kand. med. nauk. SPb, 2002.
  4. Dvoretskij L.I., Zaspa E.A., Litvitskij P.F. i dr. Svobodnoradikal'nye protsessy u bol'nyh zhelezodefitsitnoj anemiej na fone lechenija preparatami zheleza // Ter. arh. – 2006; 78 (1): 52–7.
  5. Lund E., Wharf S., Fairweather-Tait S. et al. Oral ferrous sulfate supplements in crease the free radical-generating capacity of feces from healthy volunteers // Am. J. Clin. Nutr. – 1999; 69: 250.
  6. Schrier S. So you know how to treat iron deficiency anemia // Blood. – 2015; 126: 1971.
  7. Moretti D., Goede J., Zeder C. et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women // Blood. – 2015; 126: 1981.
  8. Rüegg P. When less is really more / ETH Zurich. https://www.ethz.ch/en/news.../iron-supplementation.htm
  9. Rimon E., Kagansky N., Kagansky M. et al. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians // Am. J. Med. – 2005; 118: 1142.
  10. Tolkien Z., Stecher L., Mander A. et al. Ferrous sulfate supplementation causes significant gastrointestina side-effects in adults: a systematic review and meta-analysis // PLoS One. – 2015; 10: e0117383
  11. Auerbach M., Ballard H., Glaspy J. Clinical update: intravenous iron for anaemia // Lancet. – 2007; 369: 1502.
  12. Schrier S., Auerbach M., Mentzer W. et al. Treatment of iron deficiency anemia in adults, 2016.
  13. Dvoretskij L.I., Zaspa E.A., Vakoljuk R.M. Ctrategija i taktika vedenija bol'nyh zhelezodefitsitnoj anemiej // RMZh. – 2008; 7: 445.
  14. Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial – a prospective controlled intervention study of bariatric surgery // J. Intern. Med. – 2013; 273: 219–34.
  15. Skroubis G., Sakellaropoulos G., Pouggouras K. et al. Comparison of nutritional deficiencies after Roux-en-Y gastric bypass and after biliopancreatic diversion with Roux-en-Y gastric bypass // Obes. Surg. – 2002; 12: 551–8.
  16. Hershko C., Camaschella C. How I treat unexplained refractory iron deficiency anemia // Blood. – 2014; 123: 326.
  17. Hershko C., Hoffbrand A., Keret D. et al. Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia // Haematologica. – 2005; 90 (5): 585.
  18. Howard M., Turnbull A., Morley P. e al. A prospective study of the prevalence of undiagnosed coeliac disease in laboratory defined iron and folate deficiency // J. Clin. Pathol. – 2002; 55 (10): 754–7.
  19. Hershko C., Ronson A., Souroujon M. et al. Variable hematologic presentation of autoimmune gastritis: age-related progression from iron deficiency to cobalamin depletion // Blood. – 2006; 107 (4): 1673–9.
  20. Stetiu M., Savoye G., Lerebours E. Progression from iron deficiency anaemia to cobalamin depletion in autoimmune atrophic gastritis: is it simply a question of time? // Dig. Liver Dis. – 2006; 38 (12): 939–40.
  21. Finberg K., Heeney M., Campagna D. et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA) // Nat. Genet. – 2008; 40 (5): 569–71.
  22. Vadhan-Raj S., Strauss W., Ford D. et al. Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron // Am. J. Hematol. – 2014; 89 (1): 7.
  23. Bregman D., Morris D., Koch T. et al. Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia // Am. J. Hematol. – 2013; 88: 97.